Currier v. Stryker Corporation et al

Filing 34

ORDER signed by Judge John A. Mendez on 03/26/12 ORDERING that the 28 Motion to Dismiss is DENIED. Defendants shall file their answer to the SAC within 20 days. (Benson, A.)

Download PDF
1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 EASTERN DISTRICT OF CALIFORNIA 10 11 12 TRAVIS J. CURRIER, an individual, Plaintiff, 13 v. 14 15 16 17 STRYKER CORPORATION; STRYKER SALES CORPORATION; HOWMEDICA ONSTEONICS CORP, dba STRYKER ORTHOPAEDICS; and DOES 1-20, Defendants. 18 ) ) ) ) ) ) ) ) ) ) ) ) ) ) Case No. 2:11-CV-1203 JAM-EFB ORDER DENYING DEFENDANTS’ MOTION TO DISMISS This matter is before the Court on Defendants’ Stryker 19 20 Corporation (“Stryker”) and Howmedica Osteonics Corporation’s 21 (“Howmedica”) Motion to Dismiss (Doc. #28) Plaintiff Travis 22 Currier’s (“Plaintiff”) Second Amended Complaint (“SAC”), (Doc. 23 #26), for failure to state a claim pursuant to Federal Rule of 24 Civil Procedure 12(b)(6). 25 (Doc. #31). 26 is DENIED.1 Plaintiff opposes the motion to dismiss. For the reasons set forth below, the motion to dismiss 27 1 28 This matter was determined to be suitable for decision without oral argument. E.D. Cal. L.R. 230(g). Oral argument was scheduled for February 22, 2012. 1 1 I. 2 FACTUAL ALLEGATIONS AND PROCEDURAL BACKGROUND This action arises from a medical device that was surgically 3 implanted in Plaintiff’s leg. Plaintiff alleges that a portion of 4 his left femur was removed due to sarcoma and replaced with femoral 5 endoprothesis (a femoral stem and joined pieces), in an operation 6 that took place in December 1994. 7 ¶ 10. 8 Defendants’ product, and was dangerous and defective when it was 9 inserted into his femur. Second Am. Compl., Plaintiff alleges that the femoral endoprothesis was Second Am. Compl., ¶¶ 10-11. Plaintiff 10 was 15 at the time of the surgery. 11 ¶ 10. 12 Plaintiff, his physician and his parents that the product was of 13 superior quality and would last for Plaintiff’s lifetime, the 14 product failed and broke in February 2010. 15 12. 16 surgery to replace the product that broke. 17 12. 18 Products Liability and Negligence. 19 damages, medical expenses and lost wages. 20 Second Am. Compl., The SAC alleges that despite Defendants’ representations to Second Am. Compl., ¶ The product’s failure caused injury and necessitated further Second Am. Compl., ¶ The SAC contains two claims against Defendants for Strict Plaintiff seeks general Defendants contend that the SAC does not correct the 21 deficiencies identified by the Court in its previous Order, (Doc. 22 #25), and that the SAC should be dismissed with prejudice. 23 Court’s Order granted in part and denied in part Defendants’ motion 24 to dismiss the First Amended Complaint. 25 found that Plaintiff had failed to state a claim for Strict 26 Liability, that Defendants had not properly moved to dismiss the 27 claim for Negligence, and that Plaintiff had failed to state a 28 claim for Breach of Warranty. The Specifically, the Court Currier v. Stryker Corp., 2011 WL 2 1 4289501 (E.D. Cal. Oct. 13, 2011). The Court granted leave to 2 amend the Strict Liability claim. 3 Liability claim and renewing the Negligence claim, Plaintiff argues 4 that he has sufficiently plead his claims in the SAC. Having amended the Strict 5 6 II. OPINION 7 A. 8 A party may move to dismiss an action for failure to state a 9 Legal Standard claim upon which relief can be granted pursuant to Federal Rule of 10 Civil Procedure 12(b)(6). 11 court must accept the allegations in the complaint as true and draw 12 all reasonable inferences in favor of the plaintiff. 13 Rhodes, 416 U.S. 232, 236 (1974), overruled on other grounds by 14 Davis v. Scherer, 468 U.S. 183 (1984); Cruz v. Beto, 405 U.S. 319, 15 322 (1972). 16 are not entitled to the assumption of truth. 17 129 S. Ct. 1937, 1950 (2009), (citing Bell Atlantic Corp. v. 18 Twombly, 550 U.S. 544, 555 (2007)). 19 dismiss, a plaintiff needs to plead “enough facts to state a claim 20 to relief that is plausible on its face.” 21 570. 22 claim supportable by a cognizable legal theory. 23 Pacifica Police Department, 901 F.2d 696, 699 (9th Cir. 1990). 24 In considering a motion to dismiss, the Scheuer v. Assertions that are mere “legal conclusions,” however, Ashcroft v. Iqbal, To survive a motion to Twombly, 550 U.S. at Dismissal is appropriate where the plaintiff fails to state a Balistreri v. Upon granting a motion to dismiss for failure to state a 25 claim, the court has discretion to allow leave to amend the 26 complaint pursuant to Federal Rule of Civil Procedure 15(a). 27 “Dismissal with prejudice and without leave to amend is not 28 appropriate unless it is clear . . . that the complaint could not 3 1 be saved by amendment.” 2 316 F.3d 1048, 1052 (9th Cir. 2003). 3 B. 4 5 Eminence Capital, L.L.C. v. Aspeon, Inc., Motion 1. Strict Products Liability The first cause of action is a strict products liability claim 6 based on a manufacturing defect theory. Plaintiff alleges that 7 Defendants’ product was designed so as not to break after 8 implantation in Plaintiff’s leg. 9 included the use of composite materials which were intended to last Plaintiff alleges that the design 10 for the lifetime of the persons into which the femoral stem 11 products were implanted, and that a manufacturing, production and 12 testing process was also designed to ensure that the products were 13 of uniform composition and would not have weak areas where 14 composite material might break. 15 because the femoral stem product did break, the SAC alleges that 16 the product left Defendants’ possession with an inherent weakness 17 at the point of the break. 18 its design, the product had a defect when it was implanted which 19 made it likely to fail and break at the point where it did. 20 Am. Compl., ¶ 17. 21 sufficiently specific to allege a manufacturing defect claim. Second Am. Compl., ¶ 16. Second Am. Compl., ¶ 12. However, Contrary to Second Plaintiff argues that these allegations are 22 Defendants argue that the allegations merely state the 23 elements of a claim for manufacturing defect, and do not provide 24 sufficient factual support for a plausible manufacturing defect 25 claim. 26 describe, beyond using conclusory allegations, how the device at 27 issue was manufactured differently from other identical models. 28 Defendants argue that Plaintiff’s use of the terms “inherent In particular, Defendants contend that Plaintiff fails to 4 1 weakness” to describe the defect is vague and implies an essential 2 problem with the design of the product, not a problem occurring 3 during manufacture. 4 California recognizes three theories of product liability: 5 design defect, manufacturing defect, and failure to warn. 6 v. Endocare, 2004 WL 5237598 at *3 (C.D. Cal. Nov. 8, 2004). 7 the manufacturing defect theory, generally a manufacturing or 8 production defect is readily identifiable because a defective 9 product is one that differs from the manufacturer’s intended result 10 or from other ostensibly identical units of the same product line. 11 Lucas v. City of Visalia, 726 F.Supp.2d 1149, 1154 (E. D. Cal. 12 2010) (internal citations omitted). 13 theory posits that a suitable design is in place, but that the 14 manufacturing process has in some way deviated from that design. 15 Id. at 1155. 16 the allegations may not simply track the general elements of strict 17 products liability without pertinent factual allegations. 18 plaintiff intending to allege a manufacturing defect “must 19 identify/ explain how the [product] either deviated from 20 [defendant’s] intended result/design or how the [product] deviated 21 from other seemingly identical [product] models.” Id. 22 Yalter Under The manufacturing defect In order to state a claim for manufacturing defect, Id. A Here, the SAC sufficiently states a claim for strict product 23 liability based on a theory of manufacturing defect. 24 Plaintiff does not offer an extensive explanation of the 25 manufacturing process and how such a process differed for 26 production of the femoral stem product at issue in this case, such 27 level of detail is not necessary at this stage of the pleadings. 28 Plaintiff has alleged that the product was properly designed and 5 While 1 used proper composite materials, but that this particular femoral 2 stem product differed from the intended design because it had a 3 manufacturing flaw that caused it to have a weak spot and 4 unexpectedly break. 5 product liability claim is DENIED. 6 2. Accordingly, the motion to dismiss the strict Negligence 7 The second claim is a negligence claim, alleging that 8 Defendants owed a duty of care to Plaintiff in the manufacture, 9 production and testing process so that the femoral stem products 10 that were subject to failure were not implanted into consumers, 11 including Plaintiff. 12 use due care for Plaintiff’s safety in their design, manufacturing, 13 production and/or testing process so that their femoral stem 14 product that was implanted into Plaintiff had a weak area where it 15 could break. 16 Defendants breached that duty by failing to Second Am. Compl., ¶¶ 25, 26. Defendants contend that the allegations in the negligence 17 claim are inadequate, as they do not differentiate between 18 Defendants and do not specify what duty of care is owed. 19 Defendants further argue that the SAC alleges the elements of a 20 negligence claim but does not plead any facts to support the claim. 21 22 23 24 25 26 A negligence claim under California law requires a plaintiff to allege that the defendant owed plaintiff a legal duty, breached the duty, and that the breach was a proximate or legal cause of plaintiff’s injury. In the context of a products liability lawsuit, under a negligence theory, a plaintiff must also prove that the defect in the product was due to the negligence of the defendant. 27 In re Toyota Motor Corp. Unintended Acceleration, Marketing, Sales 28 Practices and Products Liability Litigation, 754 F.Supp.2d 1208, 6 1 2 1223 (C. D. Cal. 2010) (internal citations omitted). Here, Plaintiff has alleged that Defendants owed a duty of 3 care to Plaintiff which was breached by Defendants’ negligence in 4 the design, manufacture, production or testing of the femoral stem 5 product, and Plaintiff was injured as a result when the implanted 6 product broke. 7 was the proximate cause of the Plaintiff’s injury, the product 8 reached Plaintiff without substantial change in the condition in 9 which it was sold by Defendants, and was used by Plaintiff and 10 11 Plaintiff has alleged that Defendants’ negligence Plaintiff’s physician as anticipated by Defendants. At this stage of the litigation, the Court must take the 12 allegations in the SAC as true, and Plaintiff has sufficiently 13 alleged a claim for negligence. 14 be able to prove that Defendants were negligent in the design, 15 manufacture or testing of the broken femoral stem product remains 16 to be seen, however, the allegations of the SAC are sufficient to 17 overcome a motion to dismiss. 18 the negligence claim is DENIED. Whether Plaintiff will ultimately Accordingly, the motion to dismiss 19 20 III. ORDER 21 For the reasons set forth above, the motion to dismiss is 22 DENIED. Defendants shall file their answer to the SAC within twenty 23 (20) days of this Order. 24 25 IT IS SO ORDERED. Dated: March 26, 2012 ____________________________ JOHN A. MENDEZ, UNITED STATES DISTRICT JUDGE 26 27 28 7

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?